Cargando…

Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation

An 8-year old boy, affected by severe aplastic anemia, developed a probable pulmonary invasive aspergillosis (IA) early after a second unrelated allogeneic hematopoietic stem cell transplant (HSCT). He was treated promptly with the combination of liposomal amphotericin B and caspofungin. Despite the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesaro, Simone, Pillon, Marta, Calore, Elisabetta, Alaggio, Rita, Gamba, Piergiorgio, Bergamo, Silvia, Mainardi, Chiara, Toffolutti, Tiziana, Pegoraro, Anna, Messina, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207306/ https://www.ncbi.nlm.nih.gov/pubmed/21772955 http://dx.doi.org/10.4081/pr.2011.e18

Ejemplares similares

Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis
por: Sinatora, Francesco, et al.
Publicado: (2017)

Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease
por: Marzollo, Antonio, et al.
Publicado: (2017)

Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience
por: Calore, Elisabetta, et al.
Publicado: (2015)

A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant
por: Cesaro, Simone, et al.
Publicado: (2013)

Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor
por: Taverna, Livia, et al.
Publicado: (2017)

Current evidence of antifungal prophylaxis and therapy in pediatric patients
por: Giacchino, Mareva, et al.
Publicado: (2011)

Adenovirus Infection in Pediatric Hematopoietic Cell Transplantation: A Challenge Still Open for Survival
por: Cesaro, Simone, et al.
Publicado: (2022)

Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients
por: Busca, Alessandro, et al.
Publicado: (2016)

Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation: Past Evidence for Future Therapy of Aspergillosis
por: Thammasit, Patcharin, et al.
Publicado: (2021)

Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression
por: Kasper, Ekkehard M., et al.
Publicado: (2011)

The Impact of Chemotherapy after Pediatric Malignancy on Humoral Immunity to Vaccine-Preventable Diseases
por: Garonzi, Chiara, et al.
Publicado: (2020)

Impact of previous invasive pulmonary aspergillosis on the outcome of allogeneic hematopoietic stem cell transplantation
por: Lee, Ji Yean, et al.
Publicado: (2012)

Primary renal aspergillosis and renal stones in both kidneys associated with hematopoietic stem cell transplant
por: Park, Hyunsung, et al.
Publicado: (2010)

Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation
por: Colombatti, Raffaella, et al.
Publicado: (2011)

Psychopathological Aspects in Childhood Hematopoietic Stem Cell Transplantation (HSCT): The Perception of Parents and Adolescents
por: Zanato, Silvia, et al.
Publicado: (2017)

Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?
por: Walsh, Thomas J., et al.
Publicado: (2020)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022)

The Use of Splenectomy to Manage Platelet Transfusion Refractoriness due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation
por: Mauro, Margherita, et al.
Publicado: (2016)

Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation
por: Urbanowicz, Tomasz, et al.
Publicado: (2016)

Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation
por: Ghosh, Indranil, et al.
Publicado: (2013)

Changes of serum aspergillus galactomannan during hematopoietic stem cell transplantation in children with prior invasive aspergillosis
por: Weng, Te-Fu, et al.
Publicado: (2016)

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
por: Lindsay, Julian, et al.
Publicado: (2021)

Pathomorphogenesis of Glycogen-Ground Glass Hepatocytic Inclusions (Polyglucosan Bodies) in Children after Liver Transplantation
por: Callea, Francesco, et al.
Publicado: (2022)

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2019)

TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis
por: Bernal-Martínez, L, et al.
Publicado: (2021)

Aspergillus lentulus: An Under-recognized Cause of Antifungal Drug-Resistant Aspergillosis
por: Nematollahi, Saman, et al.
Publicado: (2021)

Not only a small liver - The pathologist’s perspective in the pediatric liver transplant setting
por: Gambella, Alessandro, et al.
Publicado: (2022)

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
por: Tissot, Frederic, et al.
Publicado: (2017)

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011)

Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis
por: Lee, Dong‐Gun, et al.
Publicado: (2019)

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
por: Durden, Emily, et al.
Publicado: (2013)

Fulminant Laryngeal-tracheobronchial-pulmonary Aspergillosis: A Rare and Fatal Complication in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Tao, Tao, et al.
Publicado: (2017)

Invasive Aspergillosis after Renal Transplantation
por: Sigera, Liyanage Shamithra Madhumali, et al.
Publicado: (2023)

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents
por: Miller, Matthew A, et al.
Publicado: (2020)

Short-Term Bisphosphonate Therapy Could Ameliorate Osteonecrosis: A Complication in Childhood Hematologic Malignancies
por: Greggio, N. A., et al.
Publicado: (2010)

Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study
por: Crone, Cornelia Geisler, et al.
Publicado: (2023)

Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy
por: Licciardello, Maria, et al.
Publicado: (2011)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

COVID-19 in Children Following Hematopoietic Cell Transplantation: A Multinational Study of the European Bone Marrow Transplantation Society (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH)
por: Averbuch, Diana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p6l6vki5vqs6o3ruer5ehjn15u